Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: Morbidity and outcome: Results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer)

Gynecologic Oncology

Volumn 102, Issue 3, 2006, Pages 523-529

  Classe, J M ^a   Rauch, P ^b   Rodier, J F ^c   Morice, P ^d   Stoeckle, E ^e   Lasry, S ^f   Houvenaeghel, G ^g  

^a CHU de Nantes   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

^c Department of Oncological Surgery   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e INSTITUT BERGONIÉ   (France)

^f CENTRE RENÉ HUGUENIN   (France)

^g Department of Oncological Surgery   (France)

Author keywords

Advanced cervical cancer; Combined chemoradiotherapy; Postoperative morbidity; Surgery

Indexed keywords

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL CLASSIFICATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATHOLOGY; PELVIS EXENTERATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT RESPONSE; URINARY DYSFUNCTION; UTERINE CERVIX CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 33748471882     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.01.022     Document Type: Article

References (34)

1. Mohar A., and Frias-Mendivil M. Epidemiology of cervical cancer. Cancer Invest. 18 (2000) 584-590
2. Fiorica J.V. Update on the treatment of cervical and uterine cancer: focus on topotecan. Oncologist 7 (2002) 36-45
3. Creasman W.T. New gynecologic cancer staging. Gynecol. Oncol. 58 (1995) 157-158
4. Leborgne F., Leborgne J.H., Doldan R., Zubizarreta E., Ortega B., Maisonneuve J., et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 37 (1997) 343-350
5. Brunschwig A., and Daniel W. Evaluation of pelvic exenteration for advanced cancer of the cervix. Surg. Gynecol. Obstet. 103 (1956) 337-341
6. Annual report on the results of treatment in gynaecological cancer. J. Epidemiol. Statist. 3 (1998) 5-34
7. Perez C.A., Grigsby P.W., Clifford Chao K.S., Mutch D.G., and Lockett M.A. Tumor size, irradiation dose, and long-term outcome of cancer of uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 41 (1998) 307-317
8. Green J.A., Kirwan J.M., Tierney J.F., Symonds P., Fresco L., Collingwood M., et al. Survival and recurrence after concurrent chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
9. Duenas-Gonzalez A., Cetina L., Mariscal I., and de la Garza J. Modern management of locally advanced cervical cancer. Cancer Treat. Rev. 29 (2003) 389-399
10. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs III C.L., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical cancer. N. Engl. J. Med. 340 (1999) 1154-1161
11. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340 (1999) 1137-1143
12. Tabata T., Takeshima N., Nishida H., Hirai Y., and Hasumi K. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell cancer of the cervix. Anticancer Res. 23 3C (2003 (May-Jun.)) 2885-2889
13. Chassagne D., Sismondi P., Horiot J.C., Sinistrero G., Bey P., Zola P., et al. A grading system for reporting complications of treatment in gynecological cancers. Radiother. Oncol. 26 (1993) 195-202
14. Mancuso S., Smaniotto D., Benedetti-Panici P., Favale B., Greggi S., Manfredi R., et al. Phase I-II trial of preoperative chemoradiation in locally advanced cervical cancer. Gynecol. Oncol. 78 (2000) 324-328
15. Burghardt E., and Pickel H. Local spread and lymph node involvement in cervical cancer. Obstet. Gynecol. 52 (1978) 138-145
16. Sismondi P., Sinistrero G., Zola P., Volpe T., Ferraris R., Castelli G.L., et al. Complications of uterine cervix cancer treatments: the problem of a uniform classification. Radiother. Oncol. 14 (1989) 9-17
17. Zola P., Magistris A., Landoni F., Sartori E., Maggino T., Gadducci A., et al. The role of the French-Italian grading system of complications in the outcome evaluation of cervical cancer treatment: an Italian multicentric study. Crit. Rev. Oncol. Hematol. 48 (2003) 317-321
18. Duenas-Gonzalez A., Lopez-Graniel C., Gonzalez-Enciso A., Cetina L., Rivera L., Mariscal I., et al. A phase II study of multi modality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann. Oncol. 14 (2003) 1278-1284
19. Benedetti-Panici P., Greggi S., Colombo A., Amoroso M., Smaniotto D., Giannarelli D., et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J. Clin. Oncol. 20 (2002) 179-188
20. Jurado M., Martinez-Monge R., Garcia-Foncillas J., Azinovic I., Aristu J., Lopez-Garcia G., et al. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery ± intraoperative electron beam radiotherapy in locally advanced cervical cancer. Gynecol. Oncol. 74 (1999) 30-37
21. Benedetti-Panici P., Maneschi F., Cutillo G., Greggi S., Salerno M.G., Amoroso M., et al. Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical cancer. Feasibility, technique, and clinical results. Cancer 78 (1996) 2359-2365
22. Maduro J.H., Pras E., Willemse P.H., and de Vries E.G. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat. Rev. 29 (2003) 471-488
23. Neoadjuvant chemotherapy for cervical cancer meta-analysis collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur. J. Cancer 39 (2003) 2470-2486
24. Higgins R.V., Naumann W.R., Hall J.B., and Haake M. Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. Gynecol. Oncol. 89 (2003) 499-503
25. Lopez-Graniel C., Reyes M., Chanona G., Gonzalez A., Robles E., Mohar A., et al. Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical cancer. Int. J. Gynecol. Cancer 11 (2001) 210-217
26. Paladini D., Raspagliesi F., Fontanelli R., and Ntousias V. Radical surgery after induction chemotherapy in locally advanced cervical cancer. A feasibility study. Int. J. Gynecol. Cancer 5 (1995) 296-300
27. Hacker N.F. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer-therapeutic advance or surgical folly?. Gynecol. Oncol. 56 (1995) 325-327
28. Morice P., Castaigne D., Pautier P., Rey A., Haie-Meder C., Leblanc M., et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical cancer. Gynecol. Oncol. 73 (1999) 106-110
29. Scambia G., Ferrandina G., Distefano M., Fagotti A., Manfredi R., Zannoni G.F., et al. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?. Gynecol. Oncol. 83 (2001) 319-324
30. Landoni F., Maneo A., Cormio G., Perego P., Milani R., Caruso O., et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol. Oncol. 80 (2001) 3-12
31. Duenas-Gonzalez A., Lopez-Graniel C., Gonzalez A., Reyes M., Mota A., Munoz D., et al. A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical cancer. Ann. Oncol. 12 (2001) 541-547
32. Perez C.A., Kuske R.R., Camel H.M., Galakatos A.E., Hederman M.A., Kao M.S., et al. Analysis of pelvic tumor control and impact on survival in cancer of the uterine cervix treated with radiation therapy alone. Int. J. Radiat. Oncol. Biol. Phys. 14 (1988) 613-621
33. Minagawa Y., Kigawa J., Irie T., Okada M., Kanamori Y., and Terakawa N. Radical surgery following neoadjuvant chemotherapy for patients with stage IIIB cervical cancer. Ann. Surg. Oncol. 5 (1998) 539-543
34. Moore D.H. Treatment of stage IB2 (bulky) cervical cancer. Cancer Treat. Rev. 29 (2003) 401-406